Jeff Bezos Is Betting Big on This Stock

If Biden wins, we’re screwed! If Biden wins, we’re screwed! [Energy and Capital logo] Jeff Bezos Is Betting Big on This Stock [Jeff Siegel Photo] By [Jeff Siegel]( Written Jul 09, 2020 If Biden wins, we’re screwed! That’s why my cousin told me last weekend, while we were having one of our obligatory drunken debates online. I wasn’t actually drunk though, as I’m partial to cannabis. But he throws back the tequila like a Mexican biker. In any event, while I love my cousin, we are pretty far apart on politics. He’s a lifelong conservative republican while I’m loyal to no party, although I tend to lean libertarian on most things. This particular debate started when he told me that if Joe Biden wins the next election, the stock market is going to crash. While it’s not uncommon for Wall Street to react negatively when Dems take office, I can’t see any justification for a full-on crash being instigated by a Biden win. In fact, JPMorgan recently opined on this, noting that a Biden win in November would be “neutral to slightly positive” for equities. Of course, no one knows for certain. And I’m not even sure it matters. After all, if you know what you’re doing, you can make money in any market. Crisis to Spawn a New Set of Millionaires? The last time government spending of this magnitude happened, one overlooked sliver of the stock market ROARED. Throwing off HUGE winners like 6,694%... 8,729%... and 23,673%. But this time around, with over $6 TRILLION in “stimulus” flooding the economy, I expect that we could see much bigger profits. [Tap here for the details.]( An Overnight Double On Monday, the NASDAQ hit a new high. Wall Street, President Trump, and many of my colleagues cheered with multiple exclamation marks. But don’t mistake record highs for a healthy economy. The fact is, this pandemic has delivered a major blow to our economy. Unemployment numbers remain dangerously high and debt burdens have gone through the roof. Not to be a doom-and-gloomer, but it’s going to take years to get employment numbers back to where they need to be. And if you think we’re dealing with excessive taxation now, wait until you see what future generations are going to be on the hook for. But my job isn’t to shine a light on that which many of us already know. My job is to help you make money –– no matter how unstable our economy has become. In fact, I would argue that it’s now more important than ever to make as much money as you can, before the proverbial poop hits the fan. And one way to do that is to invest in the companies and industries that will thrive in both good times and bad. One company I’m very bullish on right now is a small biotech firm that’s currently conducting clinical trials on a new drug that looks like it could not only completely cure chronic diseases, but even reverse them. I know, it sounds almost too good to be true. And full disclosure: Clinical trials are not yet completed. But the company just announced that it expects to release its top-line 12-week results from its Phase 2 study in Q3. This is just weeks away. If the results are positive, this stock could literally double inside of 24 hours. One Molecule Offers Second Crack at 70,000% Gains... Early investors in cannabis earned up to 70,000% gains. Enough to turn $10K into $7 million. This new breakthrough could mean 10 times higher gains. Why? As the FDA sees, it could eradicate chronic diseases like opioid addiction, depression, and others, all with one or two doses of this breakthrough medicine. This breakthrough medicine — composed of a single “magic molecule” — could claim the lion’s share of this trillion-dollar treatment market. [Find briefing on this “magic molecule” here.]( Certainly, that’s what Peter Thiel and Jeff Bezos are banking on, as both have already invested millions in this company. And I can’t say I blame them. After all, if all goes as planned, and clinical trials are successful, this treatment for chronic diseases could be worth hundreds of billions of dollars. This, according to the Longevity Fund, a venture capital firm that invests specifically in anti-aging related companies. Based on their own due diligence, the good folks over at the Longevity Fund have gone on record saying that a single age-related indication could be worth a couple hundred billion dollars That’s billion, with a “B.” It makes sense. We’re talking about not only curing things like heart disease, diabetes, and arthritis, but even reversing these diseases. But don’t just take my word for it. Take a [look at the data for yourself.]( Take a[look at the long list of billionaires that are already investing in this space.]( Hell, just [look at how this company’s technology works.]( Once you see what’s going on here, I’m willing to bet it won’t take you long to buy a few shares for yourself –– before those trial results come out next month. [Click here now](and get ready to have your mind blown! To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's [page](. the 5G Revolution Before It's Too Late The 5G revolution is still raging strong — completely ignoring COVID-19. 5G Americas' president said it best: Globally, 5G remains the fast-growing generation of wireless cellular technology ever, even as the world is gripped with a pandemic. And it makes sense. We’ve been on lockdown for months, yet there are over 63 million connections across the globe — 300% more than last year. Now we’re projecting that a complete 5G rollout is coming much sooner than we expected... soaring past $26 billion by 2022. This could be HUGE. You can still get in early, but you don’t have much time. To make it easier for you, I’ve compiled a report that details the top three stocks that could absolutely dominate this market. [Click here now to learn about each company...]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [The Central Bank Shell Game]( [Found: $57 Billion in the Trash]( [The Most Powerful Way to Trade Gold Stocks Today]( [Investing in Anti-Aging Stocks]( [Get Ready for Gold's Hyper-Bull Market]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2020, [Angel Publishing LLC](. All rights reserved. 3 E Read Street, Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.